Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. List of Tables, Figures, and Exhibits List ...
The customary approach to early-phase clinical trial design, where the focus is on identification of the maximum tolerated dose, is not always suitable for noncytotoxic or other targeted therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results